@d-and-d-world.bsky.social on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

d-and-d-world.bsky.social

did:plc:ntonj4w7w2rkxso7sqz6cvxf

Armed with positive topline results from its Phase I trial, Cereno plans to start Phase II trial for HDAC inhibitor CS014 as a treatment for idiopathic pulmonary fibrosis (IPF) in H1 2026. #news #CerenoScientific #CS014 #FibrosisResearch #IPF #PulmonaryFibrosis #ClinicalTrials #BiotechNews https://druganddeviceworld.com/2025/07/22/cerenos-ipf-drug-clears-phase-i-paving-way-for-phase-ii/?utm_source=bluesky&utm_medium=jetpack_social

2025-07-22T11:28:23.640Z